12 units of semaglutide 📚 GLP Comparison Guide: Understanding Today's GLP Therapies With so much information online, it can be difficult to understand the differences between today's GLP-based therapies. We've created this educational comparison guide to I just got my box

Med Clin North Am (2019) 103(2):26393

For a quintuple agonist with a novel peptide-drug conjugate design and a PPAR-class history of late-stage human failures, the path is longer and more uncertain

Endothelial NO synthase is expressed in thecal cells, granulosa cells, and the surface of oocyte during the follicular development

Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial

Importantly, new clinical evidence has shown that diabetic patients taking GLP-1 agonists are less likely to develop DED because of the anti-inflammatory effects on the lacrimal glands (2)